Psychosocial factors and prognosis in established coronary artery disease. the need for research on interventions
Williams, R.B.; Chesney, M.A.
JAMA 270(15): 1860-1861
1993
ISSN/ISBN: 0098-7484 PMID: 8411531 Document Number: 409153
Document emailed within 1 workday
Related Documents
Pieper, J.A. 2001: Pharmacologic interventions for coronary artery disease and risk factors. Introduction PharmacoTherapy 21(9 Pt 2): 189SLinfante, A.H.; Allan, R.; Smith, S.C.; Mosca, L. 2003: Psychosocial factors predict coronary heart disease, but what predicts psychosocial risk in women Journal of the American Medical Women's Association 58(4): 248-253
Feder, G.; Griffiths, C. 1998: Managing established coronary heart disease. Practice teams need support in organising pharmacological and lifestyle interventions Bmj 316(7127): 309
Fujimoto, Y.; Ishiwata, S.; Dohi, T.; Masuda, J.; Fujimoto, H.; Mitani, H.; Maehara, A.; Ohno, M.; Yamaguchi, T.; Tanaka, K.; Naruse, Y. 2007: Long-term prognosis after coronary revascularization in patients with end-stage renal disease on dialysis: comparison of percutaneous coronary intervention and coronary artery bypass grafting Journal of Cardiology 50(1): 11-20
Majid Ghayour-Mobarhan; Taylor, A.; Reza, S.M. Kazemi-Bajestani; Lanham, S.-New; David J Lamb; Vaidya, N.; Livingstone, C.; Wang, T.; Gordon AA Ferns 2008: Serum Zinc and Copper Status in Dyslipidaemic Patients with and without Established Coronary Artery Disease Clinical Laboratory 54(9-10): 321-329
Asai, T. 1983: Diagnosis and prognosis of coronary artery lesions in Kawasaki disease. Coronary angiography and the conditions for its application (a score chart) Nihon Rinsho. Japanese Journal of Clinical Medicine 41(9): 2080-2085
Meller, S.M.; Stilp, E.; Walker, C.N.; Mena-Hurtado, C. 2013: The link between vasculogenic erectile dysfunction, coronary artery disease, and peripheral artery disease: role of metabolic factors and endovascular therapy Journal of Invasive Cardiology 25(6): 313-319
Langewitz, W.; Kiss, A. 1991: Psychosocial risk factors and coronary heart disease Therapeutische Umschau. Revue Therapeutique 48(8): 555-559
Nie, X.-m.; Zhao, Y.-x.; Shi, D.-m.; Liu, Y.-y.; Zhou, Z.-m.; Su, L.-x.; Zhou, Y.-j. 2013: Effects of allitridi capsules on endothelial function and clinical prognosis after percutaneous coronary intervention in coronary artery disease patients with diabetes mellitus Zhonghua Yi Xue Za Zhi 93(26): 2052-2055
Marzolini, S.; Swardfager, W.; Alter, D.A.; Oh, P.I.; Tan, Y.; Goodman, J.M. 2015: Quality of life and psychosocial measures influenced by exercise modality in patients with coronary artery disease European Journal of Physical and Rehabilitation Medicine 51(3): 291-299
Savonitto, S.; Ambrosini, V.; Marzocchi, A.; Tolaro, S.; Petronio, A.S.; Galassi, A.R.; Bongo, A.S.; Gaglione, A.; Bolognese, L. 2005: Drug therapy during percutaneous coronary interventions in stable and unstable coronary artery disease: the Italian Drug Evaluation in Angioplasty (IDEA) study Italian Heart Journal: Official Journal of the Italian Federation of Cardiology 6(2): 106-118
Connelly, P.W.; Stachenko, S.; MacLean, D.R.; Petrasovits, A.; Little, J.A. 1999: The prevalence of hyperlipidemia in women and its association with use of oral contraceptives, sex hormone replacement therapy and nonlipid coronary artery disease risk factors. Canadian Heart Health Surveys Research Group Canadian Journal of Cardiology 15(4): 419-427
Park, S.J. 1998: Interventions for left main coronary artery disease: indications, technique and results Indian Heart Journal 50(Suppl 1): 74-78
Forti, N.; Diogo Giannini, S.; Diament, J.; Issa, J.; Fukushima, J.; Dal Bó, C.; Pereira Barretto, A.C. 1996: Coronary risk factors in children of young coronary artery disease patients Arquivos Brasileiros de Cardiologia 66(3): 119-123
Ning, X.-h.; Xiang, X.-p.; Lu, N.; Zhang, Y.-x.; Wang, W.-j.; Liu, Y.; Zhou, Z. 2008: Relation of risk factors to coronary artery stenosis severity in coronary atherosclerotic heart disease Zhonghua Yi Xue Za Zhi 88(18): 1267-1269
Zeiher, A.M. 1994: Endothelial modulation of coronary vasomotor tone in humans. Effects of atherosclerosis and risk factors for coronary artery disease Arzneimittel-Forschung 44(3a): 439-442
Czer, L.S.; Gray, R.J.; DeRobertis, M.A.; Bateman, T.M.; Stewart, M.E.; Chaux, A.; Matloff, J.M. 1984: Mitral valve replacement: impact of coronary artery disease and determinants of prognosis after revascularization Circulation 70(3 Part 2): I198-I207
Batyraliev, T.A.; Fetser, D.V.; Preobrazhenskiĭ, D.V.; Pershukov, I.V.; Akylbekov, M.; Belenkov, I.N. 2010: Optimal method of revascularization in patients with multivessel coronary artery involvement for application of drug eluting stents: percutaneous coronary interventions in comparison with coronary bypassing Kardiologiia 50(2): 84-90
Halim, S.A.; Wang, A.; Harrison, J.K. 2011: Anomalous right coronary artery origin from the pulmonary artery (ARCAPA) coexisting with obstructive atherosclerotic disease of the left coronary artery Journal of Invasive Cardiology 23(1): E260-E261
1990: Efficacy of exercise thallium-201 scintigraphy in the diagnosis and prognosis of coronary artery disease. American College of Physicians Annals of Internal Medicine 113(9): 703-704